Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-02-01 / J. Immunol. 2009 Feb;182(3):1667-73Hyperthermia as an adjunctive treatment for soft-tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2009-02-01 / Expert Rev Anticancer Ther 2009 Feb;9(2):199-210The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
/in International Publications, Newcastle Disease Virus /von 2009-01-31 / Cancer Immunol. Immunother. 2009 Aug;58(8):1175-84Vaccine therapy in patients with renal cell carcinoma
/in Hypernephroma, International Publications, IOZK Veröffentlichungen /von 2009-01-30 / Eur. Urol. 2009 Jun;55(6):1333-42Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice
/in International Publications, Newcastle Disease Virus /von 2009-01-28 / Liver Int. 2009 Apr;29(4):593-602Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity
/in Dendritic Cells, International Publications /von 2009-01-26 / Clin. Dev. Immunol. 2008;2008:106321Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens
/in Dendritic Cells, International Publications /von 2009-01-26 / Blood 2009 Apr;113(18):4213-23In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection
/in HIV/AIDS, International Publications /von 2009-01-23 / PLoS ONE 2009;4(1):e4256Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-01-20 / J. Dermatol. Sci. 2009 Apr;54(1):31-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de